Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grignani

Showing results (601-610 of 688) with videos related to

Pageof 69
Sort By:
Scientific Reports|December 17, 2025
Performance and clinical utility of two targeted multigene panels for GIST molecular characterizationMargherita Nannini, Annalisa Astolfi, Thais Maloberti, et al.
ESMO Open|August 9, 2024
TRAbectedin in adVanced rEtroperitoneal well differentiated/dedifferentiated Liposarcoma and Leiomyosarcoma (TRAVELL): results of a phase II study from the Italian Sarcoma GroupC Fabbroni, G Grignani, B Vincenzi, et al.
Mechanisms of Ageing and Development|June 13, 2012
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartmentChiara Lobetti-Bodoni, Dario Ferrero, Elisa Genuardi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 24, 2018
High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trialSandro Pasquali, Chiara Colombo, Sara Pizzamiglio, et al.
Journal for Immunotherapy of Cancer|November 18, 2020
Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trialJavier Martin-Broto, Nadia Hindi, Giovanni Grignani, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2017
Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patientsA Longhi, S S Bielack, R Grimer, et al.
The Oncologist|June 26, 2020
The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors: A Multicenter, European Retrospective Case Series AnalysisGiacomo Giulio Baldi, Mehdi Brahmi, Salvatore Lo Vullo, et al.
The Oncologist|July 18, 2023
KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort StudyLorena Incorvaia, Dario De Biase, Margherita Nannini, et al.
Cancers|September 9, 2022
Peripheral Inflammatory Indexes Neutrophil/Lymphocyte Ratio (NLR) and Red Cell Distribution Width (RDW) as Prognostic Biomarkers in Advanced Solitary Fibrous Tumour (SFT) Treated with PazopanibSamuel Hidalgo-Ríos, Jaime Carrillo-García, David S Moura, et al.
Cancers|April 3, 2021
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma GroupEmanuela Palmerini, Roberta Sanfilippo, Giovanni Grignani, et al.
Pageof 69

Showing results (601-610 of 688) with videos related to

Sort By:
Pageof 69
Scientific Reports|December 17, 2025
Performance and clinical utility of two targeted multigene panels for GIST molecular characterizationMargherita Nannini, Annalisa Astolfi, Thais Maloberti, et al.
ESMO Open|August 9, 2024
TRAbectedin in adVanced rEtroperitoneal well differentiated/dedifferentiated Liposarcoma and Leiomyosarcoma (TRAVELL): results of a phase II study from the Italian Sarcoma GroupC Fabbroni, G Grignani, B Vincenzi, et al.
Mechanisms of Ageing and Development|June 13, 2012
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartmentChiara Lobetti-Bodoni, Dario Ferrero, Elisa Genuardi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 24, 2018
High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trialSandro Pasquali, Chiara Colombo, Sara Pizzamiglio, et al.
Journal for Immunotherapy of Cancer|November 18, 2020
Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trialJavier Martin-Broto, Nadia Hindi, Giovanni Grignani, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2017
Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patientsA Longhi, S S Bielack, R Grimer, et al.
The Oncologist|June 26, 2020
The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors: A Multicenter, European Retrospective Case Series AnalysisGiacomo Giulio Baldi, Mehdi Brahmi, Salvatore Lo Vullo, et al.
The Oncologist|July 18, 2023
KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort StudyLorena Incorvaia, Dario De Biase, Margherita Nannini, et al.
Cancers|September 9, 2022
Peripheral Inflammatory Indexes Neutrophil/Lymphocyte Ratio (NLR) and Red Cell Distribution Width (RDW) as Prognostic Biomarkers in Advanced Solitary Fibrous Tumour (SFT) Treated with PazopanibSamuel Hidalgo-Ríos, Jaime Carrillo-García, David S Moura, et al.
Cancers|April 3, 2021
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma GroupEmanuela Palmerini, Roberta Sanfilippo, Giovanni Grignani, et al.
Pageof 69